Physicians' Academy for Cardiovascular Education

SGLT2 inhibition in the management of type 2 diabetes: Potential impact on CVD Risk

Sep. 2, 2015

Teaching slides prepared and presented by Prof. Silvio E Inzucchi, New Haven, CT, USA at EBAC accredited symposium 'Managing Diabetes & CVD: Exploring new evidence and opportunities' at ESC 2015 in London.
 

Download presentation in PDF

Lecture 3 prof Inzucchi SGLT2 inhibition in the management of type 2 diabetes.pdf (2,5MB)Lecture 3 prof Inzucchi SGLT2 inhibition in the management of type 2 diabetes.pdf (2,5MB)


Click on images to view presentation